drugset / Trial / NCT05013320
Combined Dexmedetomidine and Glycopyrrolate Therapy
Withdrawn
Kangbuk Samsung Hospital
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Catheter-related bladder discomfort after transurethral resection of bladder tumor is frequent because of indwelling urinary catheter for irrigation. The mechanism of the catheter-related bladder discomfort is similar to that of overactive bladder, in which muscarinic acetylcholine receptors are stimulated. The catheter-related bladder discomfort is a well known predisposing factor for emergence delirium after general anesthesia. In this study, we aimed to compare the incidence of catheter-related bladder discomfort between dexmedetomidine only therapy and combind dexmedetomidine and glycopyrrolate therapy.
Timeline
- Start
- 2021-09-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrrolate | Small molecule | — | Intravenous |
| Comparator | Dexmedetomidine | Other / unclassified | — | — |